In conclusion, our study revealed that MICAL2, mainly expressed in fibroblasts, is an independent and adverse prognostic factor and facilitates metastasis and the formation of immunosuppressive microenvironment in pancreatic cancer. This evidence concerns the gene MICAL2 and pancreatic neoplasm.